InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Naftzger J. Christopher, 管理人员. Officer active across 2 companies, notably Nabriva Therapeutics plc. In total, 4 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €40k. History available since 27 December 2021. The latest transaction was disclosed on 14 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
J. Christopher Naftzger is General Counsel and Corporate Secretary of Nabriva Therapeutics plc. He oversees the legal affairs and regulatory compliance of the company, ensuring its good governance.